Different mutations may coexist in the same tumor cells 15 or may be present in different areas (ie, different cells) of the tumor.33 If tumor cells carry both EGFR and ALK alterations, the two types of inhibitors may be able to kill tumor cells and could have a positive treatment effect. The gene discussed is EGFR; the disease is neoplasm.